Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
about
Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expressionTwenty Years of PSA: From Prostate Antigen to Tumor MarkerA first-generation multiplex biomarker analysis of urine for the early detection of prostate cancerLongitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseProstate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005Prostate-specific antigen testing accuracy in community practice.Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewImmunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerDiagnosis of prostate cancer via nanotechnological approachGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsEmerging PSA-based tests to improve screeningKallikreins as biomarkers for prostate cancerProstate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging rolesProstasomes are mediators of intercellular communication: from basic research to clinical implicationsA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialProstate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaNew Developments in Biomarkers for Atopic DermatitisThe effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.Using focus groups to adapt ethnically appropriate, information-seeking and recruitment messages for a prostate cancer screening program for men at high risk.Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerThe trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study.Classification of fixed urological cells using Raman tweezers.Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic diseaseDiffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancerParallel routes of human carcinoma development: implications of the age-specific incidence dataIn-silico prediction of blood-secretory human proteins using a ranking algorithm.Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.Quantitative analysis of a prostate-specific antigen in serum using fluorescence immunochromatography.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometryIncreasing the sensitivity of enzyme-linked immunosorbent assay using multiplexed electrokinetic concentrator.Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support.The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.The clinical impact of different assays for prostate specific antigen.Screening for prostate cancer: estimating the magnitude of overdetection.Near infrared photonic finger imager for prostate cancer screening.The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program.
P2860
Q22009031-E013903D-A15A-4941-B35B-1A65CCB91AF5Q24564782-B3E3FB08-658D-4E1C-B737-46ABC634F87CQ24569630-19AFAF10-E1A2-42C9-8492-CAA2BB058BDDQ24632629-963B82F6-2852-45E4-B8D3-7E505CE6044FQ24656098-857EA210-AC39-4E05-B63B-6C4558EF3DCCQ24799377-9ED298AB-622F-4D4F-8A24-2E590F5D0C3FQ26748872-F93F1F25-BC28-4E78-B371-55E0F302EE59Q26767044-09FB268E-ED6B-4D2E-93AA-1F45B30418A0Q26777322-2AAC78BA-BC5D-4544-A086-4E9A8F3655DDQ26778227-F59169D5-8963-4ECB-99ED-5095D38356AFQ26828563-49421DF7-7756-4373-AF58-B73FA60B3C9EQ26862434-4FC82167-66F3-4E83-A9E6-7481E427B691Q26865810-CAEC6704-7695-4BE2-A219-3FCEF685ABD7Q26996787-925C608F-7FE1-4A48-9C71-C6A8C76BD3FAQ27022638-A06E3D18-994E-49CA-810A-A9B6B2D1E0FEQ28085419-2B82B6E8-87E6-4B87-8EF3-8C95D1C42150Q28396611-C72F6DD4-C44C-40E7-9FC6-24B6D4DEDCB5Q30239973-AE2F14B2-7EB3-4FFB-A31A-5D2A7369F982Q30312189-0EE20ED3-0B3F-479D-9159-DBA819D3A6FDQ30472489-0E95A0F7-1616-4611-9199-57C293CE053BQ30488372-C596B61A-88EB-4D89-8EA8-D561E8285616Q30933370-A0EA0EFF-615A-4D5B-A56D-E23923C4473DQ33306300-DB0511DF-DD9A-451A-B0FB-CC185356455AQ33385858-D9FBFBF6-FF05-4354-90E3-5479CE44EDF6Q33426490-223C79DC-9DFE-4904-ACF8-5B9A863CCB54Q33449075-EE4B9CA8-9D63-4308-BEAB-F3D3ACF284E0Q33464875-FFAC9CDB-60F7-4FD8-B696-6550FBBB457BQ33506089-D2C1D9B6-155B-44A1-B12B-B3377C2402E5Q33577512-A0877BEE-1B08-4D48-B3C2-F5476875AD34Q33676037-3714D6CD-D42B-4368-A8E6-FEB4AE3D747EQ33757592-F4A43F63-C6E5-4B08-BDEE-9A5D8639AE49Q33807752-4C3C91B6-B4D1-411D-8D78-8A39823E155AQ33858150-7930DBD8-54F3-4FAA-A9B5-77E80132F04AQ33910607-AF806479-46B1-4B5E-9D3A-DD72952F7E54Q33958709-B6159080-2971-4B04-928C-45142463C6E7Q33989110-7B37D8F2-39EE-49C1-A2F1-4BEADC278F77Q34022442-5D5C36C2-21C0-4879-86D5-D003D735A226Q34030152-C940DAA7-6174-47C4-9631-38F75FE62914Q34069799-9E363BB9-26DE-4501-8D10-005E951E0E36Q34076905-E265F361-AF38-45A3-A9A8-23F65A0E9671
P2860
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Measurement of prostate-specif ...... ning test for prostate cancer.
@ast
Measurement of prostate-specif ...... ning test for prostate cancer.
@en
Measurement of prostate-specif ...... ning test for prostate cancer.
@nl
type
label
Measurement of prostate-specif ...... ning test for prostate cancer.
@ast
Measurement of prostate-specif ...... ning test for prostate cancer.
@en
Measurement of prostate-specif ...... ning test for prostate cancer.
@nl
prefLabel
Measurement of prostate-specif ...... ning test for prostate cancer.
@ast
Measurement of prostate-specif ...... ning test for prostate cancer.
@en
Measurement of prostate-specif ...... ning test for prostate cancer.
@nl
P2093
P1476
Measurement of prostate-specif ...... ning test for prostate cancer.
@en
P2093
Andriole GL
Catalona WJ
Ratliff TL
P304
P356
10.1056/NEJM199104253241702
P407
P577
1991-04-01T00:00:00Z